Takanobu Nomura
Overview
Explore the profile of Takanobu Nomura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang C, Ristuccia R, Zheng Z, Takahashi T, Nomura T, Dennis E
Clin Ther
. 2024 Oct;
46(12):1024-1033.
PMID: 39379224
Purpose: During the coronavirus disease 2019 (COVID-19) pandemic, professional organizations suggested extending dosing intervals for systemic cancer therapies to limit in-person visits. Mogamulizumab, indicated for adults with relapsed or refractory...
2.
Ristuccia R, Zhao Y, Chang C, Zhou H, Takahashi T, Nomura T, et al.
Oncol Ther
. 2024 Sep;
12(4):775-786.
PMID: 39305456
Introduction: Sézary syndrome (SS) is a rare leukemic cutaneous T cell lymphoma. This study was conducted to examine the real-world treatment patterns among patients with SS in the USA from...
3.
Hattori N, Kabata D, Asada S, Kanda T, Nomura T, Shintani A, et al.
PLoS One
. 2023 Dec;
18(12):e0269969.
PMID: 38134023
Objective: Istradefylline, a selective adenosine A2A receptor antagonist, is indicated in the US and Japan as adjunctive treatment to levodopa/decarboxylase inhibitors in adults with Parkinson's disease (PD) experiencing OFF time....
4.
Ohata C, Kanai Y, Murotani K, Yamazaki F, Takahashi H, Tada Y, et al.
Dermatol Ther (Heidelb)
. 2023 Mar;
13(4):1039-1052.
PMID: 36877438
Introduction: Evidence on treatment effectiveness in patients with psoriasis having anxiety or depressive symptoms helps shared decision-making. This single-arm, open-label, prospective study-ProLOGUE-was conducted to assess the effectiveness of brodalumab on...
5.
Mizutani Y, Kanai Y, Murotani K, Honma M, Higashiyama M, Kobayashi S, et al.
J Dermatol
. 2022 Nov;
50(3):319-326.
PMID: 36342070
Psoriasis impacts various aspects of patients' health-related quality of life and is associated with sleep problems. However, research discussing the associations between interleukin-17 blockage therapies and sleep problems in patients...
6.
Honma M, Kanai Y, Murotani K, Nomura T, Ito K, Imafuku S
J Dermatol Sci
. 2022 Feb;
105(3):189-191.
PMID: 35184912
No abstract available.
7.
Komaba H, Zhao J, Yamamoto S, Nomura T, Fuller D, McCullough K, et al.
J Cachexia Sarcopenia Muscle
. 2021 Jun;
12(4):855-865.
PMID: 34060245
Background: Wasting is a common complication of kidney failure that leads to weight loss and poor outcomes. Recent experimental data identified parathyroid hormone (PTH) as a driver of adipose tissue...
8.
Yamamoto S, Fuller D, Komaba H, Nomura T, Massy Z, Bieber B, et al.
Clin Kidney J
. 2021 Apr;
14(4):1236-1243.
PMID: 33841868
Background: Uremic toxins are associated with various chronic kidney disease-related comorbidities. Indoxyl sulfate (IS), a protein-bound uremic toxin, reacts with vasculature, accelerating atherosclerosis and/or vascular calcification in animal models. Few...
9.
Yamamoto S, Bieber B, Komaba H, Hanafusa N, Kitabayashi H, Nomura T, et al.
J Ren Nutr
. 2021 Apr;
32(2):243-250.
PMID: 33820694
Objectives: Patients undergoing hemodialysis (HD) may have poor nutritional status and hyperphosphatemia. Nephrologists sometimes manage hyperphosphatemia by prescribing phosphate binders and/or recommending restriction of dietary phosphate including protein-rich foods; the...
10.
Imafuku S, Kanai Y, Murotani K, Nomura T, Ito K, Ohata C, et al.
J Dermatol Sci
. 2021 Jan;
101(3):185-193.
PMID: 33495058
Background: Plaque psoriasis significantly affects patients' health-related quality of life. To aid treatment decisions, not only objective assessment by physicians but also subjective assessment by patients is important. Objective: To...